Source: BIOSPACE

The Alpha 1 Project: Inhibrx And The Collaborate To Develop A Recombinant Alpha-1 Antitrypsin With Improved Properties

LA JOLLA, Calif.and MIAMI, Sept. 17, 2015 /PRNewswire/ --www.inhibrx.com/" target"_blank" rel"nofollow">Inhibrx and www.thealpha-1project.com/" target"_blank" rel"nofollow">The Alpha-1 Project, Inc. (TAP), a wholly owned subsidiary...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100